Targeting Transcription Factors for Cancer Treatment.
Lambert M, Jambon S, Depauw S, David-Cordonnier MH. · 2018
Read Targeting Transcription Factors for Cancer Treatment. by Lambert M, Jambon S, Depauw S, David-Cordonnier MH. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6100431.txt.
Introduction
Lambert and co-authors review ways to drug transcription factors in cancer. Their review appeared in Molecules. Transcription factors switch genes on and off. They account for about a fifth of known oncogenes. For years they were classed as undruggable.
New structural knowledge changed that verdict. Drugs can lower a factor's production or speed its destruction. Others block its partner proteins. Some stop it binding DNA at all. A few such drugs are already in use or in trials. Modern chemistry designs molecules for these awkward targets. The review sorts the approaches by attack point. Readers get a field guide to a newly open drug frontier.
Catalog record
| CREATOR | Lambert M, Jambon S, Depauw S, David-Cordonnier MH. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 175 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |